The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury

Anandharajan Rathinasabapathy*, Alana Horowitz, Kelsey Horton, Ashok Kumar, Santhi Gladson, Thomas Unger, Diana Martinez, Gaurav Bedse, James West, Mohan K. Raizada, Ulrike M. Steckelings, Colin Sumners, Michael J. Katovich*, Vinayak Shenoy*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number180
Number of pages11
JournalFrontiers in physiology
Volume9
DOIs
Publication statusPublished - 27 Mar 2018

Keywords

  • pulmonary fibrosis
  • pulmonary hypertension
  • C21
  • AT(2) receptor
  • bleomycin
  • rats
  • RATS
  • PIRFENIDONE
  • FIBROBLASTS
  • ACTIVATION
  • DISEASE
  • STROKE
  • SYSTEM
  • CELLS

Cite this